Publications (97) FERNANDO RODRÍGUEZ SERRANO publications

filter_list

2025

  1. Cost-effectiveness of HER2/neu 655 genotyping in managing trastuzumab-induced cardiotoxicity risk in HER2-positive breast cancer patients.

    Journal of Clinical Oncology, Vol. 43, Núm. 16_suppl, pp. 543-543

  2. Influence of CYP2D6 polymorphisms on tamoxifen side effects in patients with breast cancer

    Clinical and Translational Oncology, Vol. 27, Núm. 9, pp. 3655-3663

  3. The Predictive Value of Blood-Derived Exosomal miRNAs as Biomarkers in Breast Cancer: A Systematic Review

    Clinical Breast Cancer, Vol. 25, Núm. 1, pp. e48-e55.e15

2024

  1. Endovascular Technique for Ascending Aorta Repair Based on TEVAR and TAVI Procedures

    Journal of Endovascular Therapy, Vol. 31, Núm. 3, pp. 360-365

  2. HER2/neu 655 polymorphism, trastuzumab-induced cardiotoxicity, and survival in HER2-positive breast cancer patients

    Clinical and Translational Oncology, Vol. 26, Núm. 10, pp. 2531-2540

  3. Impact of CYP2D6 polymorphisms on adverse events in patients with breast cancer treated with tamoxifen: Insights from an early dose escalation trial in CYP2D6 poor metabolizers

    Journal of Clinical Oncology, Vol. 42, Núm. 16

2023

  1. Discovery of a synthetic taiwaniaquinoid with potent in vitro and in vivo antitumor activity against breast cancer cells

    Biomedicine and Pharmacotherapy, Vol. 168

  2. Early increase in tamoxifen dose in CYP2D6 poor metaboliser breast cancer patients and survival: A propensity score matching analysis

    Breast, Vol. 69, pp. 342-348

  3. Oligometástasis en cáncer de mama: estrategias y perspectivas para el control local del tumor primario y de las metástasis

    Revisiones en Cancer, Vol. 37, Núm. 2, pp. 92-97

  4. Surgical complications in endovenous extraction of cardiac electrostimulation device infections

    Cirugia Cardiovascular, Vol. 30, Núm. 4, pp. 195-202

  5. Valve repair in mitral endocarditis

    Cirugia Cardiovascular, Vol. 30, pp. S28-S33

2022

  1. Carcinoma localmente avanzado. Hormonoterapia neoadyuvante en cáncer de mama con expresión de receptores hormonales y HER2 negativo

    Revisiones en Cancer, Vol. 36, Núm. 6, pp. 295-303

  2. Mathematical model optimized for prediction and health care planning for COVID-19

    Medicina Intensiva, Vol. 46, Núm. 5, pp. 248-258

  3. Nuevas evidencias sobre seguridad de los ECMO cebados por periodos superiores a los recomendados por los fabricantes [resumen]

    Revista Española de Perfusión, Núm. 72, pp. 21

2021

  1. Modeling COVID-19 with uncertainty in granada, spain. Intra-hospitalary circuit and expectations over the next months

    Mathematics, Vol. 9, Núm. 10

2020

  1. Immunophenotypic Conversion between Primary and Relapse Breast Cancer and its Effects on Survival

    Gynecologic and Obstetric Investigation, Vol. 85, Núm. 3, pp. 259-266

  2. Intermuscular S-ICD Implantation in Pediatric Patients

    Thoracic and Cardiovascular Surgeon, Vol. 68, Núm. 1, pp. 68-71

  3. NT-proBNP as predictor factor of cardiotoxicity during trastuzumab treatment in breast cancer patients

    Breast, Vol. 54, pp. 106-113

2019

  1. Hearing regeneration and regenerative medicine: Present and future approaches

    Archives of Medical Science, Vol. 15, Núm. 4, pp. 957-967

  2. Left superior vena cava draining into the left atrium: Clinical entities, diagnosis and surgical treatment

    Archives of Cardiovascular Diseases, Vol. 112, Núm. 2, pp. 135-143